NCCN 2012 Webinar Series: Women’s Health - Management of Hormone Receptor Negative Disease in Breast Cancer
This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Breast and Ovarian Cancer, collectively known as Women’s Health Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. These webinars will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Discuss emerging clinical trial data for triple negative breast cancers
- Apply the results of emerging clinical trial data to optimize outcome for patients with HER2-positive or triple negative breast cancer
William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician